Communication award for Auckland scientist
29 November 2012
The New Zealand Association of Scientists has this week awarded the Science Communicators Award for 2012 to Dr Siouxsie Wiles from The University of Auckland and Maurice Wilkins Centre.
Centre celebrates national research honours
21 November 2012
The Maurice Wilkins Centre is delighted that four of its investigators – Professors Margaret Brimble, John Fraser and David Williams and Dr Richard Furneaux – received prestigious awards at the annual Research Honours Dinner in Auckland this evening.
Secondary school book award for principal investigator
16 November 2012
Maurice Wilkins Centre principal investigator Professor Peter Shepherd and co-author Rachel Heeney, Head of Biology at Epsom Girls Grammar School, won the Best Book or Series in Secondary Publishing award at the Copyright Licensing New Zealand (CLNZ) Educational Publishing A...
Image-conscious researchers to meet at symposium
12 November 2012
New Zealand technologies being developed to more accurately deliver anticancer drugs, locate the sites where drugs are “switched on”, and to model the skin over a person’s entire body, are just some of the topics that will be discussed at the Maurice Wilkins Centre’s annual ...
Science day for secondary school teachers
8 November 2012
Auckland secondary school teachers yesterday received an intensive update on the latest in biomedical science at an event sponsored by the Maurice Wilkins Centre.
Promising New Zealand compound selected as drug candidate for tuberculosis
17 September 2012
A New Zealand-designed compound that shows promise against treatment-resistance tuberculosis (TB) has been selected as a drug candidate by international non-profit drug developer the Global Alliance for TB Drug Development (TB Alliance).
Centre hosts Chinese regional leaders
13 September 2012
Regional leaders from Zhejiang province yesterday visited the Maurice Wilkins Centre for Molecular Biodiscovery, to continue developing scientific links between China and New Zealand. The purpose of their visit was to discuss collaborative research projects and learn from Ne...
Local cancer drug approved for first clinical trial in United States and New Zealand
30 August 2012
The US Food and Drug Administration (FDA) has granted approval for PR610, an anticancer “stealth” drug invented in New Zealand, to move forward to human clinical trials through its approval of an Investigational New Drug (IND) Application for the drug.